The first-ever Interactive Civil Society Hearing to prepare the UN High-Level Meeting on TB took place on 4 June 2018 at the UN Headquarters in New York.

Global TB CAB welcomes introduction of safer drug for most South Africans with rifampicin-resistant TB; Other countries and the World Health Organization must now follow.

Countries and donors must do more to ensure all people with TB have access; further price reductions for newer medicines required.

The Special Rapporteur on the Right to Health releases an open letter and a thematic report drawing attention to key human rights issues in the global struggle to end TB.

The Global Drug Facility’s reduced prices are immediately available to all programs, regardless of their procurement funding source, including: national TB programs, governments, non-governmental organizations, and others.

The Global Coalition of TB Activists launches a book featuring stories of women TB survivors from all over the world.

Advocates highlight in a letter, addressed to the leadership of the United Nations High-Level Meeting on TB, key human rights commitments.

Seven fields of action should be given specific emphasis and advocated for as part of the processes around the UN High-Level Meeting on TB.

Global Drug Facility continues to strengthen its diagnostics portfolio with the launch of a new catalog and organization of first suppliers meeting.

First-ever Interactive Civil Society Hearing to prepare the UN High-Level Meeting on TB took place on 4 June 2018 at the UN Headquarters in New York.